Elanco's plans to acquire Bayer's animal health business faces further scrutiny in New Zealand
MLex Summary: A New Zealand review of US-based Elanco Animal Health's plans to acquire German pharmaceutical company Bayer's animal-health business is facing prolonged investigation by the country's competition watchdog. In a...To view the full article, register now.
Already a subscriber? Click here to view full article